Search details
1.
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med
; 385(4): 320-329, 2021 07 22.
Article
in English
| MEDLINE | ID: mdl-34192428
2.
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses.
Clin Infect Dis
; 76(10): 1822-1831, 2023 05 24.
Article
in English
| MEDLINE | ID: mdl-36578137
3.
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
Emerg Infect Dis
; 29(3): 599-604, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36703252
4.
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
Clin Infect Dis
; 75(1): e827-e837, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34928334
5.
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 422-428, 2022 Mar 18.
Article
in English
| MEDLINE | ID: mdl-35298453
6.
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
JAMA
; 328(15): 1523-1533, 2022 10 18.
Article
in English
| MEDLINE | ID: mdl-36255426
7.
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
MMWR Morb Mortal Wkly Rep
; 70(5152): 1761-1765, 2021 Dec 31.
Article
in English
| MEDLINE | ID: mdl-34968373
8.
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(13): 495-500, 2021 Apr 02.
Article
in English
| MEDLINE | ID: mdl-33793460
9.
Examination of xylene exposure in the U.S. Population through biomonitoring: NHANES 2005-2006, 2011-2016.
Biomarkers
; 26(1): 65-73, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33284648
10.
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
N Engl J Med
; 386(19): 1855-1857, 2022 05 12.
Article
in English
| MEDLINE | ID: mdl-35385628
11.
Factors Associated with Exposure to Trihalomethanes, NHANES 2001-2012.
Environ Sci Technol
; 54(2): 1066-1074, 2020 01 21.
Article
in English
| MEDLINE | ID: mdl-31865698
12.
Test negative case-control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021-2022.
BMJ Open
; 13(12): e072144, 2023 12 10.
Article
in English
| MEDLINE | ID: mdl-38072491
13.
Healthcare personnel in 2016-2019 prospective cohort infrequently got vaccinated, worked while ill, and frequently used antibiotics rather than antivirals against viral influenza illnesses.
Influenza Other Respir Viruses
; 17(9): e13189, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37693773
14.
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022.
Open Forum Infect Dis
; 10(8): ofad431, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37663086
15.
Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study.
JMIR Res Protoc
; 11(7): e37929, 2022 Jul 28.
Article
in English
| MEDLINE | ID: mdl-35635842
16.
Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021.
Influenza Other Respir Viruses
; 16(3): 585-593, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35023288
17.
COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol.
JMIR Res Protoc
; 2021 May 26.
Article
in English
| MEDLINE | ID: mdl-34057904
18.
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
Vaccine
; 39(47): 6956-6967, 2021 11 16.
Article
in English
| MEDLINE | ID: mdl-34509322
19.
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study.
JMIR Res Protoc
; 10(12): e31574, 2021 Dec 03.
Article
in English
| MEDLINE | ID: mdl-34662287
Results
1 -
19
de 19
1
Next >
>>